节点文献

灯盏细辛注射液对代谢异常老年心脑血管事件及趋向预防干预初步研究

Preliminary Study of Dengzhan Xixin Injection on Prevention and Intervention of Cardiovascular and Cerebrovascular System Disease of Older People Caused by Metabolic Disorder

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 何泮廖蔚茜郑粤文游敏玲柯学

【Author】 HE Pan, LIAO Wei-qian, ZHENG Yue-wen, et al (TCM Hospital of Luohu District, Shenzhen 518001, China)

【机构】 深圳市罗湖区中医院深圳市罗湖区中医院 广东深圳518001广东深圳518001

【摘要】 目的观察灯盏细辛注射液对代谢异常老年心脑血管事件及趋向预防干预的效果。方法52例患者1种以上代谢异常老年干预组用灯盏细辛注射液30~40mL加入生理盐水250mL中静脉滴注,每日1次,10~14d为1个疗程,约隔半年1个周期,观察期3年以上。与50例对照组比较,观察两组症状、心脑血管事件及高敏C反应蛋白(hsCRP)值的变化。结果干预组的症状改善、心脑血管事件发生率及hsCRP值均优于对照组,相比差异有显著性意义(P<0.01)。结论灯盏细辛的预防干预可有效减少患有代谢异常老年人的心脑血管事件及阻遏其发生趋势。

【Abstract】 Objective To observe the effect of Dengzhan Xixin injection on prevention and intervention of cardiovascular and cerebrovascular system disease of older people caused by metabolic disorder. Method A Group with metabolic syndrome were treated with a mixture of 30~40 mL of Dengzhan Xixin injection in 250 mL of physiological saline by intravenous injections (n=52). A treatment session was one injection once a day for 10~14 days. Each session was repeated every six months for a duration of three years. Cardiovascular and cerebrovascular disease symptoms, and changes of high sensitivity C-reactive protein (hsCRP) were measured compared with the control group (n=50). Results Compared to the control group, the intervention group had improved symptoms, lower occurrence of cardiovascular and cerebrovascular disease and ruduced hsCRP test result. The difference was significant (P<0.01). Conclusion Prevention and treatment with Dengzhan Xixin injection effectively reduces or stops the prevalance of cardiovascular and cerebrovascular system disease symptoms in older people suffering from metabolic disorder.

  • 【文献出处】 中国中医药信息杂志 ,Chinese Journal of Information on Traditional Chinese Medicine , 编辑部邮箱 ,2006年06期
  • 【分类号】R285.6
  • 【被引频次】2
  • 【下载频次】45
节点文献中: 

本文链接的文献网络图示:

本文的引文网络